Yes. J1 Global operates large‑scale production designed to support stable, long‑term supply for domestic and international partners.
Find answers to the most frequently asked questions
about J1 Global's products and services.
Yes. J1 Global operates large‑scale production designed to support stable, long‑term supply for domestic and international partners.
Yes. You can view our Interactive Facial Map and download the Injection Site Guide below.
IMPORTANT: Please note that these guidelines are intended for general reference only. The final treatment decision should be determined by the practitioner according to the patient’s skin texture, condition, and specific needs.
J1 Global applies strict raw material control, advanced cross‑linking technology, and rigorous in‑process and final inspections to support safety, purity, and batch‑to‑batch consistency.
J1 Global integrates in‑house R&D, manufacturing, and global business operations with strict quality standards and stable, scalable production.
BDDE technology supports smooth injectability, controlled cross‑linking, stable volume retention, and natural‑looking results.
DVS technology is designed to provide strong cohesiveness, shape retention, structural stability, and long‑lasting performance in appropriate indications.
J1 Global develops products using both DVS and BDDE cross‑linking technologies, allowing practitioners to select fillers based on indication, injection plane, and tissue characteristics.
J1 Global is a Korean bioscience company specializing in aesthetic medical products, including dermal fillers, skin boosters, and related professional solutions.
J1 Global offers hyaluronic acid fillers cross-linked with BDDE or DVS, PLA-based collagen biostimulators, skin boosters, medical devices such as anti-adhesion barriers, and cosmetic products such as peeling solutions.